Company: LGN
Filing Date: 2025-11-03
Form Type: DRS
Source: 0001193125-25-262782
Chunk: 165

Company: Legence Corp.
Filing Date: 2025-11-03
Form: DRS
Chunk 165
---
Nominating and Corporate Governance Committee

Our nominating and corporate governance committee consists of Terrence Keenen, Robert Mitchell Nimocks and Christie Kelly, and Terrence Keenen
serves as the chairman. As required by the rules of the SEC and listing standards of the Nasdaq, the nominating and corporate governance committee consists solely of independent directors, subject to the
phase-in exceptions. Those rules permit us to have a nominating and corporate governance committee that has one independent member at the date our Class A Common Stock is first listed on the Nasdaq, a
majority of independent members within 90 days thereafter and all independent members within one year thereafter.

This committee
identifies, evaluates and recommends qualified nominees to serve on our board of directors; develops and oversees our internal corporate governance processes and maintains a management succession plan. We have adopted a nominating and corporate
governance committee charter defining the committee’s primary duties in a manner consistent with the rules of the SEC and the listing standards of the Nasdaq.

Compensation Committee Interlocks and Insider Participation

None of our executive officers serve on the board of directors or compensation committee of another public company that has an executive
officer that serves on our board of directors or compensation committee. No

111

Confidential Treatment Requested by Legence Corp.

Pursuant to 17 C.F.R. Section 200.83

member of our board of directors is an executive officer of another public company in which one of our executive officers serves as a member of the board of directors or compensation committee of
that company.

Code of Business Conduct and Ethics

Our board of directors adopted a code of business conduct and ethics applicable to our employees, directors and officers that complies with
applicable U.S. federal securities laws and the corporate governance rules of the Nasdaq. Any waiver of this code may be made only by our board of directors and will be promptly disclosed as required by applicable U.S. federal securities laws and
the corporate governance rules of the Nasdaq.

Corporate Governance Guidelines

Our board of directors adopted corporate governance guidelines in accordance with the corporate governance rules of the Nasdaq.

112

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 COMPENSATION DISCUSSION AND ANALYSIS The purpose of this compensation discussion and analysis section is to provide information about the material elements of compensation that are paid, awarded to, or earned by, our “named executive officers,” who consist of our executive officers,